-+ 0.00%
-+ 0.00%
-+ 0.00%

Unicycive Therapeutics Q4 EPS $(0.82) Misses $0.03 Estimate

Benzinga·03/30/2026 11:53:43
Listen to the news
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate of $0.03 by 2511.76 percent. This is a 68.46 percent increase over losses of $(2.60) per share from the same period last year.